Key Takeaways on GEP Testing in Melanoma and SCC

An expert discusses when gene expression profile (GEP) testing is recommended for melanoma and squamous cell carcinoma (SCC) patients, including cases where it may not be necessary, and provides final thoughts on the utility of GEP testing in risk stratification and making treatment decisions.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 2:47

Loaded: 0%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -2:47

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

• en (Main), selected

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

EP: 1.Limitations and Challenges in Skin Cancer Staging Systems

EP: 2.Utility of Molecular Testing in Skin Cancer Risk Assessment

EP: 3.Gene Expression Profiling and Other Molecular Tests Utilized for Melanoma and Squamous Cell Carcinoma

EP: 4.Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma

EP: 5.De-Escalating Treatment Plans With Gene Expression Profiling in an 80-Year-Old Man With SCC

Now Viewing

EP: 6.Key Takeaways on GEP Testing in Melanoma and SCC

Video content above is prompted by the following:

• When do you recommend GEP testing for melanoma and SCC patients? Are there cases where GEP testing is not necessary?
• Give your final thoughts on GEP testing for melanoma and SCC and its utility in risk stratification and making treatment decisions.

Related Videos

Safety Considerations for IL-17 Inhibitors

Selecting and Dosing IL-17 Inhibitors in Psoriasis

De-Escalating Treatment Plans With Gene Expression Profiling in an 80-Year-Old Man With SCC

Balancing Education and Reassurance: Guiding Parents Through the Safety Profile of New Therapies

Essential Monitoring Considerations for Prescribing Topical JAK Inhibitors in Younger Children

Evaluating the Safety of Topical JAK Inhibitors in the Pediatric Population: Insights into Systemic Risks and Adverse Effects

Safety Considerations in Pediatric Atopic Dermatitis Treatments

Quality of Life Impact: Supporting Patients With GPP

The Challenges of Diagnosis and Management of GPP

Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies

Related Content

Advertisement

July 10th 2024

Management of Atopic Dermatitis With Hand and Foot Involvement

Related Content

Video SeriesCase-Based Peer PerspectiveMaximizing Impact and Utility of Prognostic Gene Testing in Melanoma and Squamous Cell Carcinoma

Video Series

|

Case-Based Peer Perspective

|

Maximizing Impact and Utility of Prognostic Gene Testing in Melanoma and Squamous Cell Carcinoma

Advertisement

July 10th 2024

Management of Atopic Dermatitis With Hand and Foot Involvement